J 2022

Reply to Chen et al.

FILA, Petr, Jan GOFUS, Petr NĚMEC and Jan VOJACEK

Basic information

Original name

Reply to Chen et al.

Authors

FILA, Petr (203 Czech Republic, guarantor, belonging to the institution), Jan GOFUS (203 Czech Republic), Petr NĚMEC (203 Czech Republic, belonging to the institution) and Jan VOJACEK (203 Czech Republic)

Edition

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, CARY, OXFORD UNIV PRESS INC, 2022, 1010-7940

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.400

RIV identification code

RIV/00216224:14110/22:00128254

Organization unit

Faculty of Medicine

UT WoS

000791440700001

Keywords in English

Ross operation; Pulmonary conduit; Reoperation; Reintervention

Tags

Tags

International impact, Reviewed
Změněno: 25/1/2023 09:08, Mgr. Tereza Miškechová

Abstract

V originále

We read the letter to the editor written by Chen et al. regarding our published study with great interest. We agree that the reintervention rate on both valves is of utmost importance. Therefore, we described the need for reintervention separately as follows: 9 patients (3.1%) in the Ross group had to undergo a reoperation due to autograft failure and 4 patients (1.4%) underwent a reoperation of the homograft. On the other hand, 16 patients (5.5%) underwent reoperation in the mechanical aortic valve replacement (mAVR) group. We conclude that there is no significant difference in the risk of reoperation between the Ross operation (RO) and mAVR (P = 0.54) in the mid-term postoperatively. However, only a limited number of patients in our study with a follow-up >10 years after the RO. Therefore, our ability to objectively analyse this long-term complication was limited.